{"id":"NCT00154284","sponsor":"Novartis","briefTitle":"Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients","officialTitle":"A 12 Month, Multicenter, Randomized, Parallel, Open-label Study, to Evaluate Renal Function and Efficacy of Everolimus With Basiliximab and Cyclosporine Microemulsion Discontinuation at 3 Month Post-transplant Versus Minimization, in de Novo Kidney Transplant Recipients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-07","primaryCompletion":"2008-07","completion":"2008-07","firstPosted":"2005-09-12","resultsPosted":"2011-03-11","lastUpdate":"2018-08-09"},"enrollment":114,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Organ Transplantation, Renal Transplantation"],"interventions":[{"type":"DRUG","name":"Everolimus (Certican)","otherNames":["Certican"]},{"type":"DRUG","name":"Cyclosporine (Neoral)","otherNames":["Neoral"]},{"type":"DRUG","name":"Steroid","otherNames":["Prednisone"]},{"type":"DRUG","name":"Basiliximab (Simulect)","otherNames":["Simulect"]}],"arms":[{"label":"Everolimus (Certican) with Cyclosporine (Neoral) Continuation","type":"ACTIVE_COMPARATOR"},{"label":"Everolimus (Certican) with Cyclosporine (Neoral) Withdrawal","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of everolimus in combination with basiliximab, and steroids with and without cyclosporine microemulsion in de novo kidney transplant recipients.","primaryOutcome":{"measure":"Renal Function Measured by Calculated Glomerular Filtration Rate (GFR Calculated According to the Nankivell Formula)","timeFrame":"At Month 3 and Month 12","effectByArm":[{"arm":"Everolimus (Certican) With Cyclosporine (Neoral) Continuation","deltaMin":68.5,"sd":19.92},{"arm":"Everolimus (Certican) With Cyclosporine (Neoral) Withdrawal","deltaMin":69.2,"sd":18.4}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":55},"commonTop":["Urinary tract infection","Anaemia","Oedema","Oedema peripheral","Pyrexia"]}}